AstriVax

Contact
astrivax.com
startup-iconStart-up

AstriVax NV

Ambachtenlaan 1
3001 Heverlee
Belgium
astrivax.com
Contact
Profile Products News
Contact

About AstriVax

AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax has secured a seed round of € 30 million with a strong investor syndicate to continue building the vaccine technology platform and bring the first vaccines into clinical development. The company is located in Haasrode (Leuven).

Read more about AstriVax
Facts about AstriVax
  • Founding: 2022
  • Focus : Service
  • Industry : Pharma

Product portfolio of AstriVax

Product portfolio

Show all

News about AstriVax

AstriVax

29-Aug-2022 | business & finance

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

AstriVax to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection

Read news
Show more news about AstriVax

Here you will find AstriVax NV